Investing in biotech stocks isn't for everyone because the very nature of their business is fraught with risk. As a result, ...

In a report released today, Phil Nadeau from TD Cowen maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report). The company’s ...

South Africa's Competition Commission initiated an investigation into Vertex Pharmaceuticals for alleged excessive pricing ...

Saudi Arabia’s Ministry of Industry and Mineral Resources signed a memorandum of understanding (MoU) with US-based Vertex ...

Most sickle cell disease patients who received the gene-editing therapy Casgevy have been free from vaso-occlusive crises for ...

This was the stock's second consecutive day of losses.

This favorable landscape presents an opportunity for investors to explore fundamentally strong biotech stocks with promising ...

Though M&A deal value and volume both declined in biopharma in 2024 compared to the year prior, PwC analysts still believe ...

As reported by the South China Morning Post today, Everest Medicines (HKEX 1952.HK) is accelerating its journey to become a leading biopharmaceutical company in the Asia-Pacific region, driven by ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on BioLife Solutions (BLFS – Research Report) and ...

Keros Therapeutics stock plummeted Thursday after the company stopped giving higher doses in a lung disease study due to side ...

Pfizer Inc. (NYSE:PFE) and Alliance Foundation Trials, LLC (AFT) announced results from the Phase 3 PATINA trial. The trial ...